Clinical trials
Completed Phase 4 Atherosclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
89 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 9 |
| 2004 | 5 |
| 2005 | 5 |
| 2006 | 6 |
| 2007 | 8 |
| 2008 | 4 |
| 2009 | 8 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 5 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 7 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 2 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 89 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Organon and Co | 6 |
| Johns Hopkins University | 3 |
| Radboud University Medical Center | 3 |
| University Of Perugia | 3 |
| Boston Scientific Corporation | 2 |
| Florida Atlantic University | 2 |
| Insel Gruppe AG, University Hospital Bern | 2 |
| Korea University Anam Hospital | 2 |
| Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2 |
| National Cheng-Kung University Hospital | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 89 |
| Cardiovascular Diseases | 12 |
| Coronary Artery Disease | 12 |
| Diabetes Mellitus, Type 2 | 11 |
| Inflammation | 10 |
| Coronary Disease | 8 |
| Hypercholesterolemia | 8 |
| Diabetes Mellitus | 7 |
| Angina Pectoris | 5 |
| Dyslipidemias | 5 |
Trials
Showing 1 to 25 of 89. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.